Superantigen overcomes resistance of IL-6 deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway

European Journal of Immunology

Volumn 31, Issue 8, 2001, Pages 2302-2312

  Eugster, Hans Pietro ^a   Frei, Karl ^a,b   Winkler, Frank ^a   Koedel, Uwe ^a   Pfister, Walter ^a,b,c   Lassmann, Hans ^a,c   Fontana, Adriano ^a,b,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

EAE; IL 6; Myelin oligodendrocyte glycoprotein; Neutrophil; Superantigen

Indexed keywords

INTERLEUKIN 6; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOTHELIUM CELL; GLIOSIS; IMMUNIZATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION;

EID: 0034857899     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200108)31:8<2302::aid-immu2302>3.0.co;2-%23     Document Type: Article

References (49)

1. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells
2. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation
3. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice
4. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
5. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
6. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
7. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma
8. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells
9. The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice
10. Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B
11. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial super-antigen
12. A critical role for lymphotoxin in experimental allergic encephalomyelitis
13. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis
14. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein
15. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice
16. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis
17. Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice
18. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor
19. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells
20. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component 197
21. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
22. Regulation of the B cell response to T-dependent antigens by classical pathway complement
23. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells
24. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis
25. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: Diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic beta b and T cell receptor V beta a H-2b mice
26. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen
27. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1
28. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor
29. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha
30. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function
31. Inducible expression of nuclear factor IL-6 increases endogenous gene expression of macrophage inflammatory protein-1 alpha, osteopontin and CD14 in a monocytic leukemia cell line
32. Treatment with antigranulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis
33. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
34. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion
35. Cultured murine cerebral microvascular endothelial cells contain von Willebrand factor-positive Weibel-Palade bodies and support rapid cytokine-induced neutrophil adhesion
36. Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages
37. Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus
38. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis
39. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis
40. Complement anaphylatoxin receptors on neurons: New tricks for old receptors?
41. Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis
42. The role of complement in the pathogenesis of experimental allergic encephalomyelitis
43. Rapid quantitation of neutrophil chemotaxis: Use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly
44. Attenuation of experimental autoimmune demyelination in complement-deficient mice
45. Cutting Edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice
46. Blockade of interleukin 6 trans signaling suppresses T cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
47. IL-6 is required for the development of Th1 cell-mediated murine colitis
48. The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin
49. Impaired immune and acute-phase responses in interleukin-6-deficient mice